Inhibition of this isoform seems to reduce AML cell line proliferation through effects on NF-YB and p300 [88]; whereas in other cells growth inhibition is seen only with combined Cyclin D1 and CDC25B inhibition [84]. The gene discussed is EP300; the disease is acute myeloid leukemia.